Jan 5 |
Mersana Therapeutics announces business updates, expected 2024 milestones
|
Jan 5 |
Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
|
Jan 2 |
The past three years for Mersana Therapeutics (NASDAQ:MRSN) investors has not been profitable
|
Nov 8 |
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2023 Earnings Call Transcript
|
Nov 8 |
Q3 2023 Mersana Therapeutics Inc Earnings Call
|
Nov 7 |
Mersana Therapeutics, Inc. (MRSN) Q3 2023 Earnings Call Transcript
|
Nov 7 |
Mersana Therapeutics Inc (MRSN) Reports Q3 2023 Financial Results
|
Nov 7 |
Mersana Therapeutics GAAP EPS of -$0.35 beats by $0.02, revenue of $7.7M misses by $0.98M
|
Nov 7 |
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
|
Nov 6 |
Mersana Therapeutics Q3 2023 Earnings Preview
|